Group A streptococci, attenuated (Wuhan Institute of Biological Products)

A群链球菌（武汉生物制品研究所）

Report date: 2023/11/01 11:37:46

Base Information

Drug NameGroup A streptococci, attenuated (Wuhan Institute of Biological Products)
Drug Alias NameAttenuated group A streptococci (Wuhan Institute of Biological Products)Kanserin康赛宁Kangsaining
ClassificationBiologics
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPleural Effusion, Malignant
Global Approved IndicationsPleural Effusion, Malignant
Approved Indications in ChinaPleural Effusion, Malignant
Original Approved Country/TerritoryMainland China
Original Approved Date1997/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesWuhan Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsPleural Effusion, Malignant
Inactive IndicationsN/A

Other Information

ATC CodeJ07AX
Related LinksN/A